Carlyle injects capital into Chinese lab operator

The private equity firm has invested in Adicon at a time when demand for private healthcare is growing in China.

Alison Tudor-Ackroyd

October 15, 2018

Carlyle has bought a controlling stake in Adicon, winning a competitive auction for the Chinese clinical laboratory operator.

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].